טוען...
The reduced form of coagulation factor XI is associated with illness severity and coagulopathy in critically-ill septic patients
BACKGROUND. Coagulation Factor XI (FXI) contributes to the pathobiology of sepsis-associated thrombosis and is a target for new therapeutics. Through cleavage of disulfide bonds, FXI becomes reduced (rFXI), accelerating intrinsic coagulation cascade activation. The role of rFXI in human sepsis has n...
שמור ב:
| הוצא לאור ב: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6393197/ https://ncbi.nlm.nih.gov/pubmed/30600428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-018-1797-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|